FDA Labels and a Proposed Autism Treatment

J. Carlisle Larsen outlines the FDA's planned label change for leucovorin and differing views on its readiness as an autism treatment.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!